OTIS Autoimmune Diseases in Pregnancy Project

     
You can help other pregnant women - please volunteer today!
Research into the effects of medications in pregnancy needs volunteers like you!  If you are pregnant, you may be able to help. Please call or email to learn more about these research studies.
 

Are you pregnant?
Do you have an autoimmune disease?

Call: 877-311-8972
or contact us via email
(Please include your phone number
and the best time to contact you.)

We Are Here to Answer Your Questions.

If you are pregnant and have

you may wish to get the most up-to-date information about what is known about the various medications you are taking during pregnancy. We can help. The Organization of Teratology Information Specialists* (OTIS) provides women and their health-care providers with up-to-date information about medications taken during pregnancy. When you phone OTIS, an information specialist will review all of the medications that you are taking or may be considering for use in pregnancy and provide you with the most current information available on the safety of these medications in pregnancy. All information is confidential and free of charge. Call us toll-free
(877) 311-8972
.

   
You may be eligible for the OTIS Autoimmune Diseases in Pregnancy Project

Autoimmune diseases affect many women who are in their reproductive years. Most of the medications used to treat autoimmune diseases have not been well studied for use in pregnancy.

About the research study...

The OTIS Autoimmune Diseases in Pregnancy Project is a North American effort to evaluate safety to the embryo or fetus with the use of medications in pregnancy.


OTIS is conducting this research study in an effort to gain additional information regarding autoimmune diseases, their treatment during pregnancy, and the potential effects of the treatment on the developing embryo or fetus.

If you have an autoimmune disease and are pregnant you may qualify for this research study. Eligible participants receive follow-up phone calls during pregnancy, and your child will receive a pediatric exam, performed by one of our participating physicians at no cost to you.

 
Learn More About RA Medications and Pregnancy

Please download these files for more information:

Johnson DL, Jones KL, and Chambers C. Pregnancy Outcomes in Women Exposed to Adalimumab: OTIS Autoimmune Diseases in Pregnancy Project [abstract]. Arthritis Rheum 2008; 58 (Suppl 9): S682. [pptPPT Download 416 kB]

Johnson DL, Jones KL, and Chambers C. Pregnancy Outcomes in Women Exposed to Etanercept: The OTIS Autoimmune Diseases in Pregnancy Project [abstract]. Arthritis Rheum 2008; 58 (Suppl 9): S682. [pptPPT Download 392 kB]

Review article: Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J AM ACAD DERMATOL, in press. [pdfPDF Download, 317KB]

Poster presentation: Pregnancy Outcome in Women Exposed to Leflunomide: The OTIS Autoimmune Diseases in Pregnancy Project. Presented at the ACR meeting in Washington DC Nov 2006. [PDF Download, 380 KB]

This recent publication reviews the pregnancy safety information for RA Medications and discusses this and other research studies:

Chambers CD, Tutuncu ZN, Johnson D and Jones KL. 2006. Review: Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Research & Therapy 8:225. [PDF Download, 82 KB]

   
Current Study Participants: Download Forms Here

Change of Address Form (English) [DOC Download, 32 KB]

Change of Address Form (Spanish) [DOC Download, 32 KB]

Physician Info Form (English) [DOC Download, 68 KB]

Physician Info Form (Spanish) [DOC Download, 36 KB]

Diary (English) [DOC Download, 56 KB]

Diary (Spanish) [DOC Download, 56 KB]

   
Healthcare Professionals:

Please use this form
to refer your patients to our study:

Referral Form [Fax_referral_form_AI.doc, 366KB]

Referral Form [Fax_referral_form_AI.pdf, 210KB]

Research Study Sponsors:

 

All information collected will remain strictly confidential. Identity of the women and their children will not be used in any report or publication and all files are kept in a locked cabinet. 

The coordinating center for the research study is located at the University of California, San Diego Medical Center in the Department of Pediatrics. The medical director is Dr. Kenneth Lyons Jones, a pediatrician and specialist in birth defects.

*OTIS is a national organization committed to research and the education of pregnant women and health care professionals about exposures during pregnancy.

rev. 1-December-2008